NM_206965.2:c.571G>A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP6
The NM_206965.2(FTCD):c.571G>A(p.Gly191Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000125 in 1,612,956 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_206965.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FTCD | NM_206965.2 | c.571G>A | p.Gly191Ser | missense_variant | Exon 5 of 14 | ENST00000397746.8 | NP_996848.1 | |
FTCD | NM_001320412.2 | c.571G>A | p.Gly191Ser | missense_variant | Exon 5 of 15 | NP_001307341.1 | ||
FTCD | NM_006657.3 | c.571G>A | p.Gly191Ser | missense_variant | Exon 5 of 15 | NP_006648.1 | ||
FTCD-AS1 | NR_170989.1 | n.10C>T | non_coding_transcript_exon_variant | Exon 1 of 2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152258Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000132 AC: 33AN: 250126Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135676
GnomAD4 exome AF: 0.000131 AC: 192AN: 1460698Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 98AN XY: 726648
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152258Hom.: 0 Cov.: 34 AF XY: 0.0000672 AC XY: 5AN XY: 74388
ClinVar
Submissions by phenotype
Glutamate formiminotransferase deficiency Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 191 of the FTCD protein (p.Gly191Ser). This variant is present in population databases (rs376603123, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with FTCD-related conditions. ClinVar contains an entry for this variant (Variation ID: 1385667). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt FTCD protein function with a negative predictive value of 80%. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at